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Integration of neurotransmitter and neuromodulator signals in the striatum plays a central role in the functions and
dysfunctions of the basal ganglia. DARPP-32 is a key actor of this integration in the GABAergic medium-size spiny
neurons, in particular in response to dopamine and glutamate. When phosphorylated by cAMP-dependent protein
kinase (PKA), DARPP-32 inhibits protein phosphatase-1 (PP1), whereas when phosphorylated by cyclin-dependent
kinase 5 (CDK5) it inhibits PKA. DARPP-32 is also regulated by casein kinases and by several protein phosphatases.
These complex and intricate regulations make simple predictions of DARPP-32 dynamic behaviour virtually impossible.
We used detailed quantitative modelling of the regulation of DARPP-32 phosphorylation to improve our
understanding of its function. The models included all the combinations of the three best-characterized
phosphorylation sites of DARPP-32, their regulation by kinases and phosphatases, and the regulation of those
enzymes by cAMP and Ca
2þ signals. Dynamic simulations allowed us to observe the temporal relationships between
cAMP and Ca
2þ signals. We confirmed that the proposed regulation of protein phosphatase-2A (PP2A) by calcium can
account for the observed decrease of Threonine 75 phosphorylation upon glutamate receptor activation. DARPP-32 is
not simply a switch between PP1-inhibiting and PKA-inhibiting states. Sensitivity analysis showed that CDK5 activity is
a major regulator of the response, as previously suggested. Conversely, the strength of the regulation of PP2A by PKA
or by calcium had little effect on the PP1-inhibiting function of DARPP-32 in these conditions. The simulations showed
that DARPP-32 is not only a robust signal integrator, but that its response also depends on the delay between cAMP
and calcium signals affecting the response to the latter. This integration did not depend on the concentration of
DARPP-32, while the absolute effect on PP1 varied linearly. In silico mutants showed that Ser137 phosphorylation
affects the influence of the delay between dopamine and glutamate, and that constitutive phosphorylation in Ser137
transforms DARPP-32 in a quasi-irreversible switch. This work is a first attempt to better understand the complex
interactions between cAMP and Ca
2þ regulation of DARPP-32. Progressive inclusion of additional components should
lead to a realistic model of signalling networks underlying the function of striatal neurons.
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Introduction
The basal ganglia of mammals are made up of several
nuclei forming large processing circuits in the forebrain and
controlled by mesencephalic dopamine (DA) neurons [1]. The
dorsal nigrostriatal DA pathway modulates the cortico–
striato–thalamic loop [2] involved in extrapyramidal motor
and cognitive functions. The ventral mesolimbic DA pathway
supports a variety of behavioural functions related to
motivation and reward [3]. The functional diversity of the
basal ganglia is mirrored by their involvement in pathological
conditions as diverse as Parkinson disease, Huntington
chorea, schizophrenic syndromes, and drug addiction. The
main inputs of the striatum are the excitatory glutamatergic
projections from pyramidal neurons of the cortex [4,5]. The
GABAergic medium-sized spiny neurons, which comprise
more than 95% of the striatal neurons, give rise to two kinds
of projections. A direct ‘‘stimulatory’’ pathway projects to the
output structures, internal globus pallidus, and substantia
nigra pars reticulata, while an indirect, ‘‘depressant’’ pathway
projects to the same nuclei via the external globus pallidus
and the subthalamic nucleus [6]. The indirect pathway forms
an incoherent feedforward loop (that is in the same direction
as the direct pathway but with opposite effect), that
modulates the effect of the direct pathway. The balance
between those two pathways is crucial for the function of
basal ganglia. DA released in striatum potentiates the
function of the direct pathway, through D1 receptors, and
acts as a psychostimulant (enhancing locomotion and elevat-
ing mood). In addition, DA inhibits the function of the
indirect pathway through D2 receptors. The disappearance of
this control contributes to the clinical symptoms of Parkinson
disease.
A key actor in the integration of DA and glutamate is
DARPP-32, the dopamine and cAMP-regulated phosphopro-
tein of 32 kDa (Figure 1). DARPP-32 is a protein phosphatase
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medium-sized spiny neurons of the neostriatum [7–9]. It has
been initially identiﬁed as a major target for DA signalling in
striatal neurons [10,11]. However, subsequent studies have
shown that DARPP-32 plays a wider role in the integration of
numerous signals arriving at dopaminoceptive neurons
[12,13].
DARPP-32 is phosphorylated on Thr34 by cAMP-depend-
ent protein kinase (PKA) upon activation of the cAMP
signalling pathway, for instance, by dopamine via the D1
receptors (Figure 1). This phosphorylated form (D34) acts as a
potent inhibitor of protein phosphatase-1 (PP1). PP1 affects
many signalling steps, by dephosphorylating receptors such as
AMPA and NMDA glutamate receptors, or GABAA receptors,
voltage-gated ion channels (Na
2þ, L-, and N/P-Ca
2þ), kinases
such as calcium/calmodulin kinase II, and transcription
factors (e.g., CREB), etc. (see [9] for a review). Dephosphor-
ylation of Thr34 is mediated by protein phosphatase-2B
(PP2B, also called calcineurin), upon activation of the Ca
2þ
pathway. Contrarily to inhibitor protein 1, DARPP-32
possesses several other phosphorylation sites that modulate
its ability to inhibit PP1. DARPP-32 is phosphorylated on
Thr75 by the cell division protein kinase 5 (CDK5) [14]. This
phosphorylated form (D75) acts as an inhibitor of PKA, thus
reducing the effect of dopamine signalling on PKA targets
such as AMPA glutamate receptors, MAPKKK, CREB, etc. D75
dephosphorylation is enhanced by PKA via the activation of
protein phosphatase-2A (PP2A), forming a positive feedback
loop [15]. Interestingly, activation of the Ca
2þ pathway also
leads to dephosphorylation of Thr75 [16]. The biochemical
basis of this effect is still unclear. It could be mediated by the
phosphorylation of the B9 PP2A regulatory subunit by
calcium/calmodulin kinase II [17] or via the interaction of
PP2A with the calmodulin-binding protein striatin [18]. One
can also hypothesize more indirect mechanisms, such as the
release of PP2A catalytic subunits by CaMKIV, upon binding
of Ca
2þ/calmodulin [19]. The effect of calcium therefore
creates an incoherent feedforward loop—the Ca
2þ at the
same time activating the phosphorylation on Thr34 via the
relief of PKA inhibition, and activating the dephosphoryla-
tion of Thr34 via the activation of PP2B.
It has therefore been suggested that DARPP-32 functioned
Figure 1. Biological Model of DARPP-32 Regulation
The various endogenous external signals affecting DARPP-32 through cAMP and calcium are represented, as well as external drugs. (A) nigro-striatal
medium-sized spiny GABAergic neuron; (B) nigro-pallidal medium-size spiny GABAergic neuron. Arrow-ending lines represent stimulation, bar-ending
lines represent inhibition, circle-ending lines represent enzymatic reactions. Dashed lines represent reactions only present in model B. Source is [9].
doi:10.1371/journal.pcbi.0020176.g001
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Synopsis
Projecting neurons of the striatum are a crucial relay of the basal
ganglia, involved in motor, psychomotor, and behavioural functions.
Their importance is emphasised by their involvement in various
dysfunctions, such as Huntington chorea and schizophrenia, but
also drug addiction. The main inputs to those neurons come from
cortical glutamatergic terminals. Dopamine modulates this trans-
mission, providing a measure of the internal (hedonic) state. In
mammal brain, DARPP-32, a protein phosphatase inhibitor, has been
identified as a major target for both dopamine and glutamate
signalling. The authors present a detailed quantitative model of the
regulation of DARPP-32 phosphorylation and dephosphorylation by
both signals. Dynamic simulations show that the function of DARPP-
32 depends on the delay between the two signals, and therefore the
protein not only measures the intensity, but also the coincidence,
between signals. This measurement is insensitive to many param-
eters, whether kinetic constants or concentrations, making it a
robust integrator. This shows that a proper understanding of signal
integration in the basal ganglia requires quantitative descriptions of
the signalling pathways in addition to the neuronal electrophysio-
logical properties.
DARPP-32 as a Signal Integratoras a molecular switch, acting either as a PKA inhibitor or PP1
inhibitor. The switch would be controlled by the activity of
two major signalling pathways: cAMP/PKA/D34 and Ca
2þ/
PP2B/D75. By modulating the activity of these two pathways,
it has been shown that DARPP-32 played a critical role in the
function of the cortico–striato–thalamo-cortical loop, both in
response to glutamatergic, GABAergic, and dopaminergic
inputs, but also to therapeutical drugs and drugs of abuse
[20,21]. In particular, phosphorylation of DARPP-32 on
Thr75 is a crucial factor in the sensitivity to dopamine,
greatly affected by cocaine treatment, through the modu-
lation of CDK5 activity [22].
Two other phosphorylation sites modulate DARPP-32
function. Under basal conditions, DARPP-32 is phosphory-
lated on Ser102 and Ser137, by casein kinase 2 and 1 (CK2
and CK1), respectively [23,24]. These phosphorylations in
turn modulate the phosphorylation of DARPP-32 at Thr34.
Phosphorylation on Ser137 decreases the rate of Thr34
dephosphorylation by PP2B, whereas phosphorylation on
Ser102 increases the rate of phosphorylation on Thr34 by
PKA. The activity of CK1 is suppressed by its (auto)phos-
phorylation. PP2B dephosphorylates CK1, and therefore
enhances the phosphorylation of Ser137 [25], forming
another incoherent feedforward loop, the Ca
2þ at the same
time activating and inhibiting the dephosphorylation of
Thr34. Ser137 is dephosphorylated by protein phosphatase-
2C (PP2C).
Paradoxically, the knowledge acquired about the regula-
tion of DARPP-32 function in the medium-sized spiny
neurons of the striatum is sufﬁciently detailed to make
simple ‘‘pen and paper’’ predictions of the behaviour of the
whole system a very difﬁcult, if not impossible, task. DARPP-
32 effectively represents a ‘‘hub’’ connecting at least four
kinases and three phosphatases. However, because of the
differential effects of each phosphorylation on the regulation
of the others, the ﬁnal picture is that of a whole signalling
network made up of one protein. Due to the numerous
elementary activation and inhibition steps, or positive and
negative feedback and feedforward loops identiﬁed, contra-
dictions quickly emerge when we try to consider all the
possible reactions. Numerical simulations are therefore
mandatory to gather quantitative descriptions and test
various hypotheses proposed in the literature. Previous
attempts have been made to develop quantitative models of
DARPP-32 function, but only considered phosphorylation on
Thr34 [26,27]. Lindskog and colleagues [28] also considered
phosphorylation on Thr75 (but none of the serine phosphor-
ylations).
We constructed a computational model of DARPP-32
phosphorylation. The model also included the regulation of
kinases and phosphatases by cAMP and Ca
2þ signals. The
model reproduced key behaviours experimentally observed,
such as dopamine and glutamate effects on Thr34 phosphor-
ylation, and sensitivity of the response of CDK5 activity to
cAMP. We also implemented the regulation of PP2A activity
by calcium, suggested by Nishi et al. [16], and show that
surprisingly the noticeable effect on Thr75 phosphorylation
has very minor consequences for PKA activity and Thr34
phosphorylation. In addition, the models describe several
behaviours that should be experimentally testable.
Results
Model Construction
The core of our model was centred on three phosphor-
ylation sites of DARPP-32: threonine 34, threonine 75, and
serine 137. Therefore, our DARPP-32 molecule can present
eight phosphorylation states, from the unphosphorylated to
the triply phosphorylated form (Figure 2). The transitions
between the various phosphorylation states corresponded to
12 phosphorylation reactions and 12 dephosphorylation
reactions, catalyzed by three kinases (CDK5, CK1, PKA) and
three phosphatases (PP2A, PP2B and PP2C). The phosphor-
ylation of serine 102 by CK2, which has a relatively small
effect on phosphorylation by PKA [23], was discarded from
the current version of our models. Since neither cAMP nor
calcium signals affect its phosphorylation [9], its presence or
absence would not modify the behaviour of the model upon
perturbations.
PKA is a four-subunit enzyme, composed of two regulatory
subunits and two catalytic subunits, and its regulation was
modelled as previously described [29]. In these models, each
regulatory subunit of PKA can bind two cAMP molecules,
which leads to the release of the catalytic subunits,
representing the active PKA molecules. cAMP was degraded
Figure 2. Biochemical Model of DARPP-32 Regulation
Graphical representation of the models implemented in this study.
Arrow-ending lines represent transition, either phosphorylations or
binding. Note that the bindings are reversible. Circle-ending lines
represent enzymatic reactions. The effects of kinases and phosphatases
on DARPP-32 have been represented only once for clarity, but each
couple of enzymes effectively acts on every pair of arrows of the same
colour. The different thicknesses of the red-arrowed lines represent the
catalytic rates for the various DARPP-32 species. Dashed lines represent
reactions only present in model B. Colour code of the molecular species
is the same as for Figure 1.
doi:10.1371/journal.pcbi.0020176.g002
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DARPP-32 as a Signal IntegratorTable 1. Elementary Reactions and Parameters Used in the Models
Reaction k Unit Number Reference
Model A and B common reactions DARPP-32 phosphorylations D þ CDK5 ! D-CDK5 5600000 M-1 s-1 kon1 Estimated
D-CDK5 ! D þ CDK5 12 s-1 koff1 Estimated
D-CDK5 ! D75 þ CDK5 3 s-1 kcat1 Estimated
D þ CK1 ! D-CK1 4400000 M-1 s-1 kon2 [22]
D-CK1 ! D þ CK1 12 s-1 koff2 [22]
D-CK1 ! D137 þ CK1 3 s-1 kcat2 [22]
D þ PKA ! D-PKA 5600000 M-1 s-1 kon3 [60]
D-PKA ! D þ PKA 10.8 s-1 koff3 [60]
D-PKA ! D34 þ PKA 2.7 s-1 kcat3 [60]
D34 þ CDK5 ! D34-CDK5 5600000 M-1 s-1 kon4 Estimated
D34-CDK5 ! D34 þ CDK5 12 s-1 koff4 Estimated
D34-CDK5 ! D34:75 þ CDK5 3 s-1 kcat4 Estimated
D34 þ CK1 ! D34-CK1 4400000 M-1 s-1 kon5 [22]
D34-CK1 ! D34 þ CK1 12 s-1 koff5 [22]
D34-CK1 ! D34:137 þ CK1 3 s-1 kcat5 [22]
D34 þ PP2B ! D34-PP2B 10000000 M-1 s-1 kon6 [15]
D34-PP2B ! D þ PP2B 4 s-1 kcat6 [15]
D34-PP2B ! D34 þ PP2B 16 s-1 koff6 [15]
D75 þ CK1 ! D75-CK1 4400000 M-1 s-1 kon7 [22]
D75-CK1 ! D75 þ CK1 12 s-1 koff7 [22]
D75-CK1 ! D75:137 þ CK1 3 s-1 kcat7 [22]
D75 þ PKA ! D75-PKA 5600000 M-1 s-1 kon8 [14]
D75-PKA ! D34:75 þ PKA 0 s-1 kcat8 [14]
D75-PKA ! D75 þ PKA 10.8 s-1 koff8 [14]
D75 þ PP2A ! D75-PP2A 3800000 M-1 s-1 kon9 Estimated
D75-PP2A ! D þ PP2A 10 s-1 kcat9 Estimated
D75-PP2A ! D75 þ PP2A 24 s-1 koff9 Estimated
D75 þ PP2AP ! D75-PP2AP 17000000 M-1 s-1 kon10 Estimated
D75-PP2AP ! D þ PP2AP 24 s-1 kcat10 Estimated
D75-PP2AP ! D75 þ PP2AP 40 s-1 koff10 Estimated
D137 þ CDK5 ! D137-CDK5 5600000 M-1 s-1 kon11 Estimated
D137-CDK5 ! D137 þ CDK5 12 s-1 koff11 Estimated
D137-CDK5 ! D75:137 þ CDK5 3 s-1 kcat11 Estimated
D137 þ PKA ! D137-PKA 5600000 M-1 s-1 kon12 [60]
D137-PKA ! D137 þ PKA 10.8 s-1 koff12 [60]
D137-PKA ! D34:137 þ PKA 2.7 s-1 kcat12 [60]
D137 þ PP2C ! D137-PP2C 7500000 M-1 s-1 kon13 Estimated
D137-PP2C ! D þ PP2C 3 s-1 kcat13 Estimated
D137-PP2C ! D137 þ PP2C 12 s-1 koff13 Estimated
D34:75 þ CK1 ! D34:75-CK1 4400000 M-1 s-1 kon14 [22]
D34:75-CK1 ! D34:75 þ CK1 12 s-1 koff14 [22]
D34:75-CK1 ! D34:75:137 þ CK1 3 s-1 kcat14 [22]
D34:75 þ PP2A ! D34:75-PP2A 3800000 M-1 s-1 kon15 Estimated
D34:75-PP2A ! D34 þ PP2A 10 s-1 kcat15 Estimated
D34:75-PP2A ! D34:75 þ PP2A 24 s-1 koff15 Estimated
D34:75 þ PP2AP ! D34:75-PP2AP 17000000 M-1 s-1 kon16 Estimated
D34:75-PP2AP ! D34 þ PP2AP 24 s-1 kcat16 Estimated
D34:75-PP2AP ! D34:75 þ PP2AP 40 s-1 koff16 Estimated
D34:75 þ PP2B ! D34:75-PP2B 10000000 M-1 s-1 kon17 [15]
D34:75-PP2B ! D34:75 þ PP2B 1600 s-1 koff17 [15]
D34:75-PP2B ! D75 þ PP2B 4 s-1 kcat17 [15]
D34:137 þ CDK5 ! D34:137-CDK5 5600000 M-1 s-1 kon18 Estimated
D34:137-CDK5 ! D34:137 þ CDK5 12 s-1 koff18 Estimated
D34:137-CDK5 ! D34:75:137 þ CDK5 3 s-1 kcat18 Estimated
D34:137 þ PP2B ! D34:137-PP2B 75000 M-1 s-1 kon19 [22]
D34:137-PP2B ! D137 þ PP2B 0.03 s-1 kcat19 [22]
D34:137-PP2B ! D34:137 þ PP2B 0.12 s-1 koff19 [22]
D34:137 þ PP2C ! D34:137-PP2C 7500000 M-1 s-1 kon20 Estimated
D34:137-PP2C ! D34 þ PP2C 3 s-1 kcat20 Estimated
D34:137-PP2C ! D34:137 þ PP2C 12 s-1 koff20 Estimated
D75:137 þ PKA ! D75:137-PKA 5600000 M-1 s-1 kon21 [14]
D75:137-PKA ! D34:75:137 þ PKA 0 s-1 kcat21 [14]
D75:137-PKA ! D75:137 þ PKA 10.8 s-1 koff21 [14]
D75:137 þ PP2A ! D75:137-PP2A 3800000 M-1 s-1 kon22 Estimated
D75:137-PP2A ! D137 þ PP2A 10 s-1 kcat22 Estimated
D75:137-PP2A ! D75:137 þ PP2A 24 s-1 koff22 Estimated
D75:137 þ PP2AP ! D75:137-PP2AP 17000000 M-1 s-1 kon23 Estimated
D75:137-PP2AP ! D137 þ PP2AP 24 s-1 kcat23 Estimated
D75:137-PP2AP ! D75:137 þ PP2AP 40 s-1 koff23 Estimated
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DARPP-32 as a Signal IntegratorTable 1. Continued.
Reaction k Unit Number Reference
D75:137 þ PP2C ! D75:137-PP2C 7500000 M-1 s-1 kon24 Estimated
D75:137-PP2C ! D75 þ PP2C 3 s-1 kcat24 Estimated
D75:137-PP2C ! D75:137 þ PP2C 12 s-1 koff24 Estimated
D34:75:137 þ PP2A ! D34:75:137-PP2A 3800000 M-1 s-1 kon25 Estimated
D34:75:137-PP2A ! D34:137 þ PP2A 10 s-1 kcat25 Estimated
D34:75:137-PP2A ! D34:75:137 þ PP2A 24 s-1 koff25 Estimated
D34:75:137 þ PP2AP ! D34:75:137-PP2AP 17000000 M-1 s-1 kon26 Estimated
D34:75:137-PP2AP ! D34:137 þ PP2AP 24 s-1 kcat26 Estimated
D34:75:137-PP2AP ! D34:75:137 þ PP2AP 40 s-1 koff26 Estimated
D34:75:137 þ PP2B ! D34:75:137-PP2B 75000 M-1 s-1 kon27 Estimated
D34:75:137-PP2B ! D34:75:137 þ PP2B 120 s-1 koff27 Estimated
D34:75:137-PP2B ! D75:137 þ PP2B 0.03 s-1 kcat27 Estimated
D34:75:137 þ PP2C ! D34:75:137-PP2C 7500000 M-1 s-1 kon28 Estimated
D34:75:137-PP2C ! D34:75 þ PP2C 3 s-1 kcat28 Estimated
D34:75:137-PP2C ! D34:75:137 þ PP2C 12 s-1 koff28 Estimated
CK1 phosphorylation CK1P þ PP2B ! CK1P-PP2B 30000000 M-1 s-1 kon29 Estimated
CK1P-PP2B ! CK1P þ PP2B 24 s-1 koff29 Estimated
CK1P-PP2B ! CK1 þ PP2B 6 s-1 kcat29 Estimated
CK1 ! CK1P 1 s-1 kcat30 Estimated
PDE phosphorylation PDE þ PKA ! PDE-PKA 6000000 M-1 s-1 kon31 Estimated
PDE-PKA ! PDEP þ PKA 9 s-1 kcat31 Estimated
PDE-PKA ! PDE þ PKA 36 s-1 koff31 Estimated
PDEP ! PDE 0.1 s-1 kcat32 Estimated
PP2A phosphorylation PP2A þ PKA ! PP2A-PKA 10000000 M-1 s-1 kon33 [52]
PP2A-PKA ! PP2A þ PKA 16 s-1 koff33 [52]
PP2A-PKA ! PP2AP þ PKA 4 s-1 kcat33 [52]
PP2AP ! PP2A 5 s-1 kcat34
PP2B activation PP2Bi þ 2Ca ! PP2BiCa2 10
15 M-2 s-1 kon35 [29]
PP2BiCa2 þ 2Ca ! PP2B 3 10
15 M-2 s-1 kon36 [29]
PP2BiCa2 ! PP2Bi þ 2Ca 1 s-1 koff35 [29]
PP2B ! PP2BiCa2 þ 2Ca 1 s-1 koff36 [29]
PKA activation R2C2 þ cAMP ! cAMP-R2C2 54000000 M-1 s-1 kon37 [29]
cAMP-R2C2 þ cAMP ! cAMP2-R2C2 54000000 M-1 s-1 kon38 [29]
cAMP2-R2C2 þ cAMP ! cAMP3-R2C2 75000000 M-1 s-1 kon39 [29]
cAMP3-R2C2 þ cAMP ! cAMP4-R2C2 75000000 M-1 s-1 kon40 [29]
cAMP-R2C2 ! R2C2 þ cAMP 33 s-1 koff37 [29]
cAMP2-R2C2 ! cAMP-R2C2 þ cAMP 33 s-1 koff38 [29]
cAMP3-R2C2 ! cAMP2-R2C2 þ cAMP 110 s-1 koff39 [29]
cAMP4-R2C2 ! cAMP3-R2C2 þ cAMP 32.5 s-1 koff40 [29]
cAMP4-R2C þ PKA ! cAMP4-R2C2 18000000 M-1 s-1 kon41 [29]
cAMP4-R2C2 ! cAMP4-R2C þ PKA 60 s-1 koff41 [29]
cAMP4-R2 þ PKA ! cAMP4-R2C 18000000 M-1 s-1 kon42 [29]
cAMP4-R2C ! cAMP4-R2 þ PKA 60 s-1 kon43 [29]
cAMP degradation cAMP þ PDE ! cAMP-PDE 2520000 M-1 s-1 kon44 Estimated
cAMP-PDE ! cAMP þ PDE 40 s-1 koff44 Estimated
cAMP-PDE ! AMP þ PDE 10 s-1 kcat44 Estimated
cAMP þ PDEP ! cAMP-PDEP 5040000 M-1 s-1 kon45 Estimated
cAMP-PDEP ! cAMP þ PDEP 80 s-1 koff45 Estimated
cAMP-PDEP ! AMP þ PDEP 20 s-1 kcat45 Estimated
Ca in 2.5.10
 8 M.s-1 k57 Estimated
Ca_destroy 0.6 s-1 k58 Estimated
Model B supplementary reactions PP2A activation by Ca/Nishi D34:75 þ PP2ACa ! D34:75-PP2ACa 3800000 M-1 s-1 kon46 Estimated
D34:75-PP2ACa ! D34 þ PP2ACa 10 s-1 kcat46 Estimated
D34:75-PP2ACa ! D34:75 þ PP2ACa 6 s-1 koff46 Estimated
D34:75:137 þ PP2ACa ! D34:75:137-PP2ACa 3800000 M-1 s-1 kon47 Estimated
D34:75:137-PP2ACa ! D34:137 þ PP2ACa 10 s-1 kcat47 Estimated
D34:75:137-PP2ACa ! D34:75:137 þ PP2ACa 6 s-1 koff47 Estimated
D75 þ PP2ACa ! D75-PP2ACa 3800000 M-1 s-1 kon48 Estimated
D75-PP2ACa ! D þ PP2ACa 10 s-1 kcat48 Estimated
D75-PP2ACa ! D75 þ PP2ACa 6 s-1 koff48 Estimated
D75:137 þ PP2ACa ! D75:137-PP2ACa 3800000 M-1 s-1 kon49 Estimated
D75:137-PP2ACa ! D137 þ PP2ACa 10 s-1 kcat49 Estimated
D75:137-PP2ACa ! D75:137 þ PP2ACa 6 s-1 koff49 Estimated
D34:75 þ PP2APCa ! D34:75-PP2APCa 17000000 M-1 s-1 kon50 Estimated
D34:75-PP2APCa ! D34 þ PP2APCa 24 s-1 kcat50 Estimated
D34:75-PP2APCa ! D34:75 þ PP2APCa 10 s-1 koff50 Estimated
D34:75:137 þ PP2APCa ! D34:75:137-PP2APCa 17000000 M-1 s-1 kon51 Estimated
D34:75:137-PP2APCa ! D34:137 þ PP2APCa 24 s-1 kcat51 Estimated
D34:75:137-PP2APCa ! D34:75:137 þ PP2APCa 10 s-1 koff51 Estimated
PLoS Computational Biology | www.ploscompbiol.org December 2006 | Volume 2 | Issue 12 | e176 1623
DARPP-32 as a Signal Integratorinto AMP by phosphodiesterase (PDE), which was itself
activated by PKA [30]. Ca
2þ, produced, for instance, by the
activation of NMDA receptors, was modelled as a controlled
ﬁxed inﬂux with a basal rate, changed upon perturbation, and
an efﬂux depending on the concentration of Ca
2þ. Note that
in our model, adenylyl cyclase was not Ca
2þ-sensitive, and
therefore cAMP and PKA were neither activated nor
inhibited by Ca
2þ. Although we are aware that adenylyl
cyclase V, abundantly expressed in striatum, is inhibited by
Ca
2þ [31,32], our focus was the integration of cAMP and Ca
2þ
signals at the level of DARPP-32.
The activation of PP2B was modelled following a simpliﬁed
scheme by binding two pairs of Ca
2þ ions to an inactive form
of the enzyme without explicit representation of calmodulin.
CK1 is a ubiquitous serine protein kinase in eukaryotic
organisms, which targets a wide range of substrates and
participates in a large number of processes [33]. ‘‘CK1’’ is
actually a protein family including at least seven isoforms in
mammals and their various splice variants. Isoforms and
variants display different kinase activity and tissue expression
or subcellular localization. Isoforms alpha, delta, and epsilon
are expressed in neurons of the striatum [25,34,35]. Interest-
ingly, isoforms delta and epsilon are subject to inhibitory
autophosphorylation on the COOH-terminal regulatory
domain [36–38]. To analyse the level of this auto-inactivation
and its inﬂuence on the signal integration by DARPP-32, we
included an autophosphorylation of CK1 in our model.
The model also included the following four modulations. 1)
DARPP-32 phosphorylated on Thr75 (D75, D75:137) were
very poor substrates for PKA, resulting in a competitive
inhibition [14]. Since our models assume an absence of
product rebinding, the forms phosphorylated on Thr34 do
not bind to PKA, and the multiple phosphorylations D34:75
and D34:75:137 do not inhibit PKA. To account for the fact
that D75* are also poor substrates for PP2B [15,39], the
dissociation constant of D75* with PP2B was increased,
assuming that phosphorylation was impairing the association
between the two molecules. 2) all four forms of DARPP-32
phosphorylated on Ser137 (D137, D34:137, D75:137,
D34:75:137, collectively named D137*) were poor substrates
for PP2B [24]. This was translated in the model by modiﬁed
association, dissociation, and catalytic constants of reactions
performed by PP2B on D137*. 3) PP2A was stimulated upon
phosphorylation by PKA [15]. 4) CK1 was activated upon
dephosphorylation by PP2B [36].
One of the major questions about the DARPP-32 role as an
integrator of signals, is the observed dephosphorylation of
Thr75 following activation of NMDA and AMPA receptors. As
suggested by Nishi et al. [16], dephosphorylation of Thr75
could be mediated through Ca
2þ-dependent activation of
PP2A. We therefore constructed model B, identical to model
A, but including binding of Ca
2þ on PP2A, formation of a
catalytically more active form of PP2A, and therefore
stimulation of Thr75 dephosphorylation activity (dotted
arrows on Figure 2).
All elementary reactions are listed in Table 1. The
enzymatic processes were decomposed into three elementary
steps, without any assumptions of equilibrium or steady-state
(see Discussion). Quantitative parameters were extracted
from literature or databases, or estimated, so that basal
conditions at the equilibrium matched concentrations of the
various DARPP-32 species observed in vivo [9]. The values of
the parameters we used are listed in Table 1 (except for
sensitivity analysis, in which several values were tested,
Figures 5, 7, and 8). All the reactions were assumed to take
place in the volume of a dendritic spine, which we evaluated
at 10
 15 L [40].
Dynamic Simulation of the Models and Comparison with
Experimental Results
We analysed the behaviour of our two models (model A and
model B) perturbed in different ways: 1) by a pulse of cAMP,
which represented the activation of adenylate cyclase by
dopamine D1 receptors; 2) by a train of Ca
2þ spikes, which
represented the activation of glutamate NMDA receptors; 3)
by a pulse of cAMP followed by a train of Ca
2þ spikes, to
analyse the modulation by dopamine of the response to
glutamate.
Before the perturbations, the simulation was run until a
stable state was reached for each molecular species. Initial
conditions are listed in Table 2. Initially, in the absence of
cAMP, the system did not contain any active PKA. On the
contrary, free Ca
2þ concentration reached ;1.5 10
 8 M after
equilibrium, and a basal activity of PP2B was therefore
Table 1. Continued.
Reaction k Unit Number Reference
D75 þ PP2APCa ! D75-PP2APCa 17000000 M-1 s-1 kon52 Estimated
D75-PP2APCa ! D þ PP2APCa 24 s-1 kcat52 Estimated
D75-PP2APCa ! D75 þ PP2APCa 10 s-1 koff52 Estimated
D75:137 þ PP2APCa ! D75:137-PP2APCa 17000000 M-1 s-1 kon53 Estimated
D75:137-PP2APCa ! D137 þ PP2APCa 24 s-1 kcat53 Estimated
D75:137-PP2APCa ! D75:137 þ PP2APCa 10 s-1 koff53 Estimated
PP2A þ Ca ! PP2ACa 200000 M-1 s-1 kon54 Estimated
PP2ACa ! PP2A þ Ca 1 s-1 koff54 Estimated
PP2ACa þ PKA ! PP2ACa-PKA 10000000 M-1 s-1 kon55 Estimated
PP2ACa-PKA ! PP2APCa 4 s-1 kcat55 Estimated
PP2ACa-PKA ! PP2APCa 16 s-1 koff55 Estimated
PP2AP þ Ca ! PP2APCa 200000 M-1 s-1 kon56 Estimated
PP2APCa ! PP2AP þ Ca 1 s-1 koff56 Estimated
PP2APCa ! PP2ACa 5 s-1 kcat56 Estimated
doi:10.1371/journal.pcbi.0020176.t001
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In our initial conditions, after reaching equilibrium, un-
phosphorylated DARPP-32 represented ;57% of total
DARPP-32, D75* ;35%, D137* ;13%, and D75:137 ;4%.
The total amount of DARPP-32 in the system was 3000
molecules, corresponding to a concentration of 5310
 6 Mi n
a total volume of 10
 15 L.
cAMP Pulse
cAMP activation was simulated by introducing 4000
molecules of cAMP into the system (equivalent to 6.6 3 10
 6
M). cAMP molecules bound the regulatory subunits of PKA,
which led to the dissociation of the catalytic subunits, which
in turn led to phosphorylation of DARPP-32 on Thr34
(Figure 3). At the peak of activity, 1000 molecules (1.7 3 10
 6
M) of catalytic PKA subunits are available. D34* peaked after
20 seconds, reaching ;89% of DARPP-32. Following the
degradation of cAMP by PDE and the reassociation of the
catalytic subunits of PKA with its regulatory subunits, Thr34
phosphorylation decayed exponentially, due to the basal
activity of PP2B. Upon activation of the cAMP pathway, we
also observed a decrease of D75* from 35% to 25%, caused by
the potentiation of PP2A by active PKA. A decrease of D137*
to 7.7% was caused by the segregation of PP2B by D34*,
resulting in a decrease in CK1 activation and therefore a
decrease of Ser137 phosphorylation. This effect was con-
ﬁrmed by another simulation: removing the autophosphor-
ylation of CK1 suppressed the effect of cAMP pathway
activation on Ser137 phosphorylation (unpublished data).
While D75 and D137 return to their basal levels quite rapidly,
after about 1 minute, only two-thirds of the D34 has
disappeared after half an hour.
Since the Ca
2þ pathway was not activated in this experi-
ment, models A and B presented the same behaviour upon
the sole activation of the cAMP pathway.
Ca
2þ Spikes
Activation of the Ca
2þ pathway was performed by
repeatedly increasing the inﬂux rate of Ca
2þ into the system,
from 2.5310
 8 Ms
 1 to 6.6310
 6 Ms
 1 , every 4 s for 2 s. This
triggered the formation of a series of spikes during which
Ca
2þ transiently reached a concentration of 4 3 10
 6 M, then
decayed to its basal level. The two models A and B exhibited
different behaviours upon activation of the Ca
2þ pathway. In
model A, without Ca
2þ activation of PP2A, Ca
2þ spikes
increased Ser137 phosphorylation, up to ;32% (Figure 4).
The increase of this phosphorylation was performed by
consuming unphosphorylated DARPP-32 (which dropped to
42%) or by phosphorylating D75. The total level of
phosphorylation on Thr75 was found almost not modiﬁed.
This result is not consistent with in vivo experiments on rats
that showed a dephosphorylation of DARPP-32 on Thr75
triggered by the activation NMDA receptors. We therefore
tested model B, which included the activation of PP2A by
Ca
2þ suggested by Nishi et al. [16]. Phosphorylation of
DARPP-32 on Ser137 upon activation of the Ca
2þ pathway
was observed at the same rate as in model A. However, we
observed a decrease of D75*, as observed in vivo. The levels of
unphosphorylated DARPP-32 dropped as in model A, due to
the increased phosphorylation on Ser137. However, during
the calcium spikes, this decrease was counteracted by the
increased dephosphorylation of D75. Overall, D137 was
produced mainly from unphosphorylated DARPP-32 rather
than from D75, resulting in lower D75:137 double phosphor-
ylations (unpublished data).
cAMP Pulse Followed by Ca
2þ Spikes
To study the modulatory effect of D1 receptor activation
on glutamate signals, we ran simulations where both cAMP
and Ca
2þ pathways were activated at different time intervals.
The simulation run consisted, after reaching steady state, of a
cAMP pulse followed by a train of Ca
2þ spikes. The delay
between the two activations was variable, ranging between 0
and 1000 s. This covers the short dopamine–glutamate
interactions described, for instance, in Kotter and Wickens
(1995) [9], but also the long lasting psychostimulation
observed after dopamine has been increased, for instance,
by nicotine or cocaine [41,42].
Figure 5 shows a typical result of the activation of the
cAMP pathway, followed after 50 s by activation of the Ca
2þ
pathway. Using model A, the cAMP pulse led to phosphor-
ylation of Thr34 and dephosphorylation of both Thr75 and
Ser137 (Figure 5A). When the Ca
2þ pathway was activated,
increases of unphosphorylated DARPP-32 and phosphoryla-
Table 2. Initial Conditions
Initial Conditions
Molecule Volume 10
 15 l
Number of Molecules Concentration (M)
D UniProt: Q9UD71 3000 4.98 10
 6
CDK5 UniProt: Q03114 120 2 10
 7
CK1 UniProt: Q99PS2 100 1.66 10
 7
PDE CluSTr:RAT:173779:65.3 1204 2 10
 6
PP2A CluSTr:RAT:3266:98.0 120 2 10
 7
PP2B_inactive CluSTr:RAT:1115745:100.0, RAT:165778:120.2 200 3.32 10
 7
PP2C UniProt: Q9Z1Z6 80 1.33 10
 7
R2C2 CluSTr:RAT:163232:44.5 4000 6.64 10
 6
All the other pools were empty at the start of the simulations. UniProt is the Universal Protein Resource, and can be found at http://www.uniprot.org/. CluSTr is an automated classification
of UniProt content, that allows choice of sets of proteins at different levels of sequence similarity, and can be found at http://www.ebi.ac.uk/CluSTr.
doi:10.1371/journal.pcbi.0020176.t002
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phosphorylation plunged, due to the activation of PP2B. The
phosphorylation of Thr75 slowly increased at the end of PKA
activation to reach its steady state. This phosphorylation was
unaffected by the Ca
2þ spikes in model A. Model B behaved
similarly upon increase of cAMP (Figure 5B) except that D75*
decreased due to the activation of PP2A by Ca
2þ.
After the Ca
2þ activation ended, PP2B activity dropped,
and total D34* quickly returned to the situation that followed
the cAMP pulse. This translated into a transient increase of
Thr34 phosphorylation, followed by a slow return to
equilibrium. We used the relaxation time corresponding to
the period between the minimum level and the transient
maximum level of Thr34 phosphorylation reached during the
relaxation phase as a characteristic of the ‘‘sharpness’’ of the
response to glutamate signals (see Figure 5A). Figure 6A
shows a superimposition of the different simulations, with a
delay between cAMP and Ca
2þ activation ranging from 0 to
750 s. Figure 6B shows the dependency of the relaxation time
on the delay between the cAMP pulse and the calcium spikes.
When the delay between the activation of both signals
increased, the sharpness of Thr34 dephosphorylation de-
creased, showing that the coherence of the response between
dopamine and glutamate signals depends on the time
separating both activation pathways.
Sensitivity Analysis
To analyse the robustness of the models to various
parameters, we examined two characteristics of the variation
of D34 in response to Ca
2þ after cAMP: (i) the minimum level
of Thr34 phosphorylation, characterising the ‘‘amplitude’’ of
the response to Ca
2þ; and (ii) the relaxation of the response,
as deﬁned in the previous experiment. We chose these aspects
of the response as a molecular indicator of the interaction
between DA and glutamate to assess the importance of
various factors in the regulation of DARPP-32. We ran
sensitivity analysis experiments, studying the response of the
models to the double perturbation, changing one or two
parameters at a time. Below we present the result of this
analysis for several parameters that displayed interesting
behaviours. Those parameters are the activity of CDK5, CK1
auto-inhibition rate, the activation of PP2A by PKA, and the
concentration of DARPP-32. We also evaluated the role of the
inhibitory effect of D75* on PKA. In vitro, D75 inhibits
phosphorylation of DARPP-32 on Thr34 by PKA. However,
the level of this inhibition is not quantitatively known, either
with D75 or D75:137 forms. Our sensitivity analyses were
conducted at different levels of PKA inhibition, by varying
the values of kcat8 and kcat21, the catalytic constants of
Figure 3. Effect of a Pulse of cAMP on DARPP-32 Phosphorylation
Time-course of DARPP-32 isoforms after a pulse of cAMP. Brown line
represents the number of cAMP molecules. Orange line represents the
total number of PKA catalytic subunits not bound to regulatory subunits.
DARPP-32 species are represented in black (unphosphorylated), red
(D34*), blue (D75*), and green (D137*).
doi:10.1371/journal.pcbi.0020176.g003
Figure 4. Effects of a Train of Ca
2þ Spikes on DARPP-32 Phosphorylation
Time-course of DARPP-32 isoforms triggered by a train of Ca
2þ spikes.
Bordeaux line represents the number of calcium ions in the dendritic
spine. Colour code of DARPP-32 isoforms is the same as for Figure 3. In
the absence of a cAMP signal, the phosphorylation on Thr34 remains
null. (A) model A; (B) model B.
doi:10.1371/journal.pcbi.0020176.g004
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respectively (see Table 1).
Role of CDK5. DARPP-32-linked signalling pathway being
thought to depend on the balance between Thr34 and Thr75
phosphorylations, we studied the role of CDK5 activity, which
is responsible for Thr75 phosphorylation. Both models A and
B showed similar behaviours. However, these behaviours
depended on two parameters: the level of activity of CDK5
and the level of inhibition of PKA by D75* (Figure 7A). When
PKA inhibition was high or complete (kcat8 and kcat21 ; 0),
that is, the default case, Thr34min decreased when CDK5
activity increased. When CDK5 activity was high, Thr34min
decreased when kcat8 and kcat21 decreased. The explanation
comes from the functional equivalence, as far as PKA
regulation is concerned, between an increase of CDK5
activity (more D75*) and a decrease of kcat8 and kcat21
(stronger inhibition of PKA by D75*). In contrast, when PKA
inhibition was poor (kcat8 and kcat21 ; 2.7, that is, the same
value as for the other forms of DARPP-32), then Thr34min
increased with CDK5 activity. This apparent contradiction
can be explained by the effect of Thr75 phosphorylation on
the dephosphorylation of Thr34 by PP2B, which counteracted
the effect of PKA. With little inhibition of PKA, an increase of
D75* resulted in an increase of D34*. Hence, with an
intermediate inhibition of PKA by D75*, the sensitivity of
the models to CDK5 activity is a curve showing a minimum.
Very low or high values of CDK5 activity similarly reduce the
response to glutamate signals. In the former case, there is not
enough D75* to inhibit PKA, and in the latter, the
concentration of D75* is sufﬁcient to trigger its phosphor-
ylation on Thr34, despite the low activity of PKA.
Role of PP2A. We also examined the sensitivity of the
system to the phosphorylation of PP2A by PKA that increases
its dephosphorylation activity on Thr75 (Figure 7B). Interest-
ingly, no dramatic change was observed in either of the
models, Thr34min and relaxation times hardly displaying any
changes. When the stimulation of PP2A by PKA decreases
(i.e., when koff33 and koff55 increase), the dephosphorylation
of Thr75 diminishes, and therefore the inhibition of PKA by
D75* increases. That should result in a lower Thr34min.
However, the robustness of the coupling PKA–PP2A in our
model can be explained by a segregation effect, the decrease
of complexes PKA–D75* being compensated by more PKA–
PP2A complexes. Therefore, PP2A effectively acts as a
competitive inhibitor of PKA for DARPP-32.
Role of CK1. To dissect out the role of CK1, we studied the
sensitivity of the Ca
2þ response to the catalytic rate of CK1
autophosphorylation (Table 1, kcat30). When the catalytic
constant of this reaction increased, we observed an increase
of the Ca
2þ effect on Thr34 phosphorylation, that is, a
decrease of Thr34min (Figure 8A). This was expected since
the auto-inhibition of CK1 led to decreased Ser137 phos-
phorylation, and in turn less inhibition of Thr34 dephos-
phorylation by PP2B. However, we also observed an
unexpected and unusual pattern for the sharpness of the
response. Indeed, the relaxation time reached a minimal
value at a particular catalytic rate (Figure 8B). This rate is
very close to the one chosen as the default, based on a
completely different rationale, that is, the minimal level of
double D34:75 phosphorylations. Both models A and B
displayed a similar sensitivity pattern, correctly reﬂecting
the independence of Ser137 and Thr75 phosphorylations.
Moreover, the auto-inhibition of CK1 is not affected by a
change in PKA inhibition mediated by D75*. This is expected
since CK1 inhibition and activation depends only on PP2B
activity.
Inﬂuence of DARPP-32 concentration. The concentration
of DARPP-32 has been measured by crude biochemical
approaches. In the striatum, it is thought to be in the range
from micromolar to tens of micromolar. To evaluate the
effect of DARPP-32 concentration on its function, we ran
simulations with concentrations varying from 0.6 micromolar
to 80 micromolar. Surprisingly, the time-course of D34* after
a pulse of cAMP and calcium spikes stayed very similar across
all concentrations (Figure 9). The absolute values were
Figure 5. Effect of One Pulse of cAMP Followed by a Train of Ca
2þSpikes
on DARPP-32 Phosphorylation
Time-course of DARPP-32 isoforms triggered by a pulse of cAMP
followed by a train of Ca
2þ spikes. Colour code of DARPP-32 isoforms is
the same as for Figure 3. Relax and Thr34min show the two readouts
used in sensitivity analysis. (A) model A; (B) model B.
doi:10.1371/journal.pcbi.0020176.g005
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but the shape remained qualitatively the same. Between 0.6
micromolar and 10 micromolar, the time-courses were almost
identical. At higher concentrations, the decay of D34*
became slower, as was the recovery from calcium signals.
More importantly, the ratio between the minimal D34*
reached after calcium signals and the maximal D34* reached
after a cAMP pulse stays constant (about 10%) whatever the
concentration of DARPP-32.
In Silico Site-Directed Mutagenesis
To study the role of Ser137 phosphorylation, we built
alternative models mimicking mutants. By setting all the
catalytic constants of CK1 on DARPP-32 to 0, we emulated
the behaviour of a mutant that can bind to CK1, but cannot
be phosphorylated, equivalent, for instance, to a serine 137 to
alanine mutant. Not surprisingly, the main effect of this
change was to enhance the effect of calcium on Thr34
dephosphorylation by suppressing the incoherent feedfor-
ward loop through PP2B/CK1/Ser137 (Figure 10A). The effect
on Thr75 was almost nil, which is coherent with the absence
of cross-talk between Thr75 and Ser137 regulations (Figure
10B). More interesting than the effect on Thr34min was the
effect on the relaxation time. For very short delays (inferior
to 50 s), the mutant presented longer relaxation time, while
for longer delays, its responses were sharper (Figure 6B).
Although this effect was not very large (about 10% at 1000 s),
it results in a less-efﬁcient detection of the delay between
signals, where the inhibition of PP1 differs less when the delay
between cAMP and calcium varies.
By setting up all the catalytic constants of PP2C on DARPP-
32 to 0, we can emulate, after equilibrium, a mutant with
constitutive Ser137 phophorylation. This mutant was a quasi-
irreversible switch. Because Ser137 phosphorylation strongly
inhibits Thr34 dephosphorylation, the effect of a cAMP pulse
was long-lasting. Calcium spikes had little effect on the
amount of D34*. The basal activity of PP2B decreased D34*
very slowly. After three days, two-thirds of the DARPP-32 was
still phosphorylated on Thr34. The effect of this mutant on
Thr75 phosphorylation is probably due to the fact that PKA is
not inhibited by D34:75, and therefore more PKA is available
to activate PP2A and dephosphorylate Thr75.
Discussion
Model Building
We built the model using classical chemical kinetics. We are
conscious that due to the small size of a spine, some molecules
represented in our models were present in a relatively low
number of copies. Random ﬂuctuations could therefore have
a non-negligible impact [43]. Similarly, it is obvious that the
well-stirred assumption (homogeneous distribution of mole-
Figure 6. Effect of the Delay between cAMP and Calcium Stimuli
(A) Time-course of D34* in model B, triggered by a pulse of cAMP, followed, after a variable delay, by a train of Ca
2þ spikes.
(B) Relaxation time of DARPP-32 response to calcium in function of the delay between cAMP pulse and Ca
2þ spikes. Green diamonds represent the
response of ‘‘wild-type’’ DARPP-32, while red triangles represent the response of a mutant without Ser137 phosphorylation.
doi:10.1371/journal.pcbi.0020176.g006
Figure 7. Cross-Sensitivity to the Inhibition of PKA by DARPP-32 and the
Activity of CDK5 or the Stimulation of PP2A by PKA
Values corresponding to model A are blue, while values corresponding
to model B are magenta.
(A) Cross-sensitivity to the inhibition of PKA by DARPP-32 and the activity
of CDK5. Note the inverse relationship between CDK5 activity and
Thr34min for strong inhibition of PKA (low kcat) while the relationship is
reversed at weak inhibition.
(B) Cross-sensitivity to the inhibition of PKA by DARPP-32 and the
stimulation of PP2A by PKA.
doi:10.1371/journal.pcbi.0020176.g007
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modelled using stochastic discrete simulations [44]. However,
the lack of quantitative data (microscopic constants, precise
localization, etc.) renders such an approach very inaccurate
except in very speciﬁc cases. In addition, molecules varying
widely and reaching very low numbers where stochastic
simulations would be really necessary, such as Ca
2þ, have a
signiﬁcant impact on the model only when their concen-
tration is high, that is, when the relative noise is low. Note
that in the case of Ca
2þ, the increase and decrease of
concentration are very quick compared with the other
reactions of the model (phosphorylations and dephosphor-
ylations). As a consequence, the use of population-based
stochastic approaches, such as Gillespie derivatives, would
not have changed the conclusions drawn from the simu-
lations.
In E-Cell3, enzymatic reactions may be modelled using
various kinetic laws. We used two of them: the Briggs–
Haldane [45] derivation of Henri–Michaelis–enten [46,47]
uni–uni kinetics (BH), or Mass Action Law (MAL). We
assumed all enzymatic reactions were irreversible and that
the enzyme-product species were negligible (i.e., transitory).
However, depending on the kinetic law used, the treatment of
enzyme-substrate complex was different. In BH, the complex
enzyme substrate is assumed to be in a quasi–steady state.
Therefore, net velocity of the BH kinetics does not require
explicit calculation of enzyme substrate. On the other hand,
using MAL to model enzymatic reactions requires the explicit
description of all the intermediate species of the reaction,
and the computation of their quantities.
We ﬁrst constructed our DARPP-32 models using BH as the
kinetic law for all enzymatic reactions. The ﬁrst simulation
results we obtained using these models showed unexpected
results. Mass conservation was not respected within cyclic
reactions pathways. In particular, the sum of all DARPP-32
moieties was not constant.
To investigate this problem further, we studied a stripped-
down version of the model, consisting of one cyclic reaction
pathway, modelling the double-phosphorylation states Thr34
and Thr75. In this mini-model, containing eight reactions, the
PP2A/CDK5 couple of enzymes acts on Thr75 phosphoryla-
tion, and the PP2B/PKA couple acts on Thr34 phosphoryla-
tion. We discovered that, using BH kinetics, modifying the
activity of only one couple of enzymes, e.g., PP2B/PKA
changing the phosphorylation state at Thr34, also led to a
change in the phosphorylation state at Thr75 despite no
change in activity of PP2A/CDK5, which should be actually
unchanged according to the law of mass conservation. This
discrepancy is explained by the nonlinearity of BH. Because
of different initial conditions on the parallel reactions, the
resulting ﬂuxes are not the same. In other words, there is not
the same proportionality between the rate of production and
the substrate concentration. A similar problem was reported
in models of the MAP kinase cascade [48]. Subsequently, we
chose to construct the same minimodel using MAL as the
kinetic law for all enzymatic reactions. This required all
enzyme-substrate complexes to be described. Moreover,
reactions constants (association, dissociation, and catalytic
constants) had to be estimated from experimental data, and
usually calculated from Briggs–Haldane kinetic data (Km and
Vmax). Using MAL, we found that simulations gave accurate
results, the behaviour of the model being the expected one.
Effect of Parameter Modifications
When building a reasonably large model like the one
presented here, one necessarily has to estimate many
parameters. Although these estimates are based on rational
thinking (orthologous reactions in other organisms, function
of similar enzymes, computation based on physical con-
straints, etc.), it is nevertheless important to verify that the
conclusions of the study do not depend too much on the
modeller’s guesses. In addition, robustness and fragility can
shed light on various aspects of a systems function [49,50].
Sensitivity analysis to the auto-inhibition rate of CK1 shows
there are speciﬁc values that optimize the sharpness of the
response to a Ca
2þ activation following a cAMP signal, and
dramatic inﬂuence on the amplitude of Thr34 phosphoryla-
tion. This shows that the auto-inhibition of CK1 is an
important parameter in the system, since it inﬂuences the
dynamic of integration of dopamine signalling by DARPP-32.
Interestingly enough, the ‘‘optimal’’ value, i.e., the value
Figure 8. Sensitivity to the Auto-Phosphorylation Activity of CK1
(A) Sensitivity of Thr34min to the autophosphorylation activity of CK1.
The maximal values of the x-axis correspond to a very fast auto-inhibition
of CK1, with effects identical to a Ser137Ala mutation, see red curve on
Figure 10A.
(B) Sensitivity of the relaxation time after calcium signal (the ‘‘sharpness’’
of the response) to the autophosphorylation activity of CK1.
doi:10.1371/journal.pcbi.0020176.g008
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kcat¼1s
 1, that is, the value we chose as default (Figure 8B).
This value was chosen by a completely different criterion, as
the one giving the minimal amount of D34:75:* phosphory-
lated forms. One could hypothesize that the regulation of
DARPP-32 is ﬁnely tuned to discriminate between Thr34 and
Thr75 phosphorylation, therefore dissociating PP1 and PKA
inhibition. This demonstrates that the intricacy of control
elements leads to a tradeoff between parameters, and
nontrivial optimisation of the response and integration of
cAMP and Ca
2þ signals.
Sensitivity analysis shows that models A and B are both
insensitive to changes in PKA-dependent PP2A stimulation
(Figure 7B). This means that increasing the dephosphoryla-
tion rate at Thr75 by means of PKA-stimulated PP2A does
not signiﬁcantly affect the kinetic of Thr34 phosphorylation
response to glutamate signalling. This contrasts with the
results of a change of CDK5 activity (Figure 7A) and can be
explained by the fact that changing CDK5 activity affects the
basal phosphorylation at Thr75, and therefore the inhibition
of PKA by DARPP-32. As a consequence, the basal level of
phosphorylation at Thr34 is highly affected. This conﬁrms the
experimental studies on the effect of increased basal CDK5
activity, which showed a decrease of the effect of (cocaine-
induced) dopamine signalling on Thr34 [20]. Conversely,
increasing the stimulation of PP2A by PKA does not
signiﬁcantly change the basal level of phosphorylation at
Thr75, but only the Thr75 response to cAMP pathway
activation, which changes its amplitude of dephosphoryla-
tion/phosphorylation. Thus, the effect on PP2A activity
through PKA is more transient than a change of the balance
CDK5/PP2A. Our results show the ﬁne-tuning between the
different targets of PKA: PP2A, PDE, and DARPP-32, due to
the high connectivity of the system.
Nishi and colleagues [15] showed that in the case of
dopamine stimulation, i.e., cAMP increase, D34 and D75 were
mutually antagonistic. However, the same authors showed
afterward [16] that in the case of a glutamate stimulation, D34
and D75 were decreased together. One of the outcomes of the
simulation derived from our model is that DARPP-32 is
actually not a bistable switch. Although PKA/PP2A/D75 form
a positive-feedback loop, the basal activity of CDK5 and PP2B
in our model precludes the establishment of a bistable state,
DARPP-32 being unable to be locked at 0% D75 or 100% D34
in wild-type situation (the situation is different in the case of
a constitutive D137 mutant). One condition that facilitates
the emergence of bistability is the presence of high-order
reactions in the feedback loop [51]. One possible mechanism
of PP2A regulation by PKA is known. The potentiation of
phosphatase activity is due to the phosphorylation of the
PP2A regulatory subunit by PKA (it has been demonstrated
for the B99 family so far) [52]. There are several phosphor-
ylation sites on the regulatory subunit, but we are not aware
of any indication that they trigger cooperativity. As far as we
can tell, any of the phosphorylations trigger the release of the
catalytic subunit.
DARPP-32 as a Robust Signal Integrator
When the quantity of DARPP-32 was changed in the model,
by up to two orders of magnitude, we observed a linear
scaling of the D34* response (Figure 10). The global time-
course of the response to a cAMP pulse followed by calcium
spikes was conserved, but more importantly the ratio between
the maximal D34* after cAMP and the minimal D34* after
calcium is conserved. At higher concentrations, the decay of
D34* became slower as was the recovery from calcium signals.
This is particularly visible for the highest concentration, 80
micromolar, of DARPP-32 (although it is to be noted that
such concentrations are huge, and very unlikely, despite what
was reported earlier). This slower behaviour does not affect
qualitatively the relative effects of cAMP and calcium.
Therefore, the interplay of cAMP and calcium signals is
conserved even at different concentrations of DARPP-32.
Knock-out mice were produced for DARPP-32 [20], but,
unfortunately, no phenotypes were reported on heterozygous
animals, making it impossible to evaluate a dose-effect.
The delay between the cAMP signals and the calcium spikes
Figure 9. Dependency of the Signal Integration on the Concentration of
DARPP-32
Same simulation paradigm as the one depicted in Figure 5, but with
different concentrations of DARPP-32, all the other parameters being
conserved. Only D34* of model B is plotted. While the x-axis remains the
same for all time-courses, the y-axis is scaled to superpose all the traces.
The vertical scaling is roughly linear, that is, a 2-fold increase between
successive values of DARPP-32.
(A) Calcium spikes started 50 s after the pulse of cAMP.
(B) Calcium spikes started 200 s after the pulse of cAMP.
doi:10.1371/journal.pcbi.0020176.g009
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DARPP-32 as a Signal Integratorsigniﬁcantly affects the relaxation time after calcium-induced
Thr34 dephosphorylation (Figure 6). This shows that the
coherence of the response between dopamine and glutamate
signals depends on the time separating both activation
pathways. DA, through the production of cAMP, modulates
the duration of the response to glutamate. In turn, this points
to the role of DARPP-32 as a signal integrator, since the relief
of PP1 inhibition is related to the integral of the decrease of
D34* (the area contained in the ‘‘well’’ caused by the calcium
spikes). Note that this relation is not simple. Indeed,
Thr34min, that is, the remaining DARPP-32 able to inhibit
PP1, depends on delay. Therefore, the inhibition of PP1
would be different even if the area under the curve was the
same.
The delays studied ranged from a fraction of a second to
several minutes, so as to cover interstimulus intervals
observed in electrophysiological and behavioural paradigms
[9,41,42].
The effect of the delay between cAMP and calcium signals
is attenuated in a mutant Ser137Ala. DARPP-329s function of
signal integrator is therefore impaired, and the effect of
calcium on the relief of PP1 inhibition should be more
independent of the previous cAMP signals.
In none of the sensitivity analyses performed did we
observe a meaningful difference between models A and B.
Although we successfully reproduce the observation of Nishi
et al. [16] that Thr75 was decreased in response to calcium,
this has little effect on PP1 inhibition. If there is a
physiological consequence, it is probably mediated by the
relief of PKA inhibition and its effect on targets other than
DARPP-32 (such as AMPA receptors).
The model should now be extended upstream and down-
stream. Some forms of adenylate cyclase and PDE present in
the striatum are sensitive to calcium [32,53,54]. An explicit
modelling of these enzymes is therefore needed. To integrate
cAMP and calcium signalling with other signalling systems,
one needs also to model the effect of DARPP-32 on PP1
targets, such as ERK [55]. Finally, calmodulin and calcium/
calmodulin kinase II need to be modelled explicitly in order
to take into account the complexity of calcium effects.
Phosphorylated by four different kinases, dephosphory-
lated by three different protein phosphatases, and inhibiting
a kinase and a phosphatase, DARPP-32 is one of the hubs of
neuronal signalling. Since all those enzymes are themselves
regulated by various signalling pathways, DARPP-32 acts as a
computing unit [56] that could serve as a switchboard,
modulating PKA and/or PP1 activity according to a whole
ordered set of inputs. However, contrary to what was
sometimes suggested before, our simulations show that
DARPP-32 is not a sharp Thr34/Thr75 molecular switch.
Upon activation of the cAMP pathway, we observed a
dramatic change in the phosphorylation state of DARPP-32,
which leads to a high level of D34*. But the participation of
Thr75 dephosphorylation is much less important than what
we thought. On the contrary, in this case, the pool of
unphosphorylated DARPP-32 plays a major role in the
conversion of DARPP-32 into a potent inhibitor of PP1.
Moreover, as simulated with model B and in accordance with
Nishi et al. [16], activation of the Ca
2þ pathway leads to a
simultaneous dephosphorylation at Thr34 and Thr75. Thus,
the activity of DARPP-32 is ﬁnely regulated by different
factors.
Because of the intricacy of its regulations, DARPP-32 is a
robust signal integrator that not only ﬁlters the cortico–
striatal inputs based on the internal state, but does so in a
timely manner. An elevation of dopamine decreases the PP1-
mediated inhibition of glutamatergic potentiation. It does
that not only by counteracting the level of DARPP-32
dephosphorylation, but also by shutting down this dephos-
phorylation, an effect depending on the recency of the
dopamine signal. The full complement of DARPP-32 phos-
phorylations is needed to get the full extent of this effect.
Materials and Methods
Modelling and simulation software. Modelling and simulation were
performed using the E-cell system version 3 [57] release 3.1.103
(http://www.e-cell.org/). The models are provided under E-Cell native
format and in the Systems Biology Markup Language as Datasets S1–
S4. E-cell system is an object-oriented software suite for modelling,
simulation, and analysis of large-scale complex systems such as
Figure 10. In Silico Site-Directed Mutagenesis of DARPP-32
Same simulation paradigm as the one depicted in Figure 5, but
describing the predicted behaviour of mutants by model B. Wild-type
DARPP-32 species are represented in green, Ser137Ala in red, and
constitutive Ser137P in blue. (A) D34*; (B) D75*.
doi:10.1371/journal.pcbi.0020176.g010
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DARPP-32 as a Signal Integratorbiological cells. The simulation environment uses a variable-process
model, where a variable represents a molecular species and a process
represents the kinetic law which results in a change in the value of a
variable (the quantity of a molecular species). Each process is
attached to a stepper, which decides the iteration step and performs
the calculation. E-Cell supports various steppers, such as differential
equation solvers. A generic ODEStepper developed by Kazunari
Kaizu was used for the elementary reactions. The idea is to combine
different types of single-step embedded Runge-Kuttas, rather than
the using multistep methods that have been the norm. The speciﬁc
combination used, Radau-5 þ Dormand-Prince 4(5)7M, is the only
generally available solver of this type (Kouichi Takahashi, personal
communication), and is thought to be the best setting for computa-
tional cell biology problems by E-Cell developers. XPP-Aut [58]
version 5.6 (http://www.math.pitt.edu/;bard/xpp/xpp.html), was also
used to quickly test speciﬁc features of the models. The SBML
versions of the models were tested on SBMLodeSolver (http://www.tbi.
univie.ac.at/;raim/odeSolver/) directly or via CellDesigner (http://
www.celldesigner.org/) and COPASI (http://www.copasi.org/). Simula-
tions were performed on Intel-based computers under GNU/Linux,
either on a monoprocessor desktop or a PC Farm at the European
Bioinformatics Institute.
Reaction parameters. Reactions were modelled using either a mix
of Briggs–Haldane and MAL processes, or solely with MAL processes.
In the latter case, the enzymatic reactions were decomposed into
three elementary steps. Association (kon), dissociation (koff), and
catalytic (kcat) constants were usually calculated from published
kinetic constants, retrieved from BRENDA (http://www.brenda.uni-
koeln.de/), from DOQCS (http://doqcs.ncbs.res.in/), or taken from
other published models [29,59]. Elementary constants were obtained
from Km using empirical methods.
Other parameters were estimated to match concentrations of the
various DARPP-32 species observed in vivo [9]. All the parameters are
listed in Table 1.
Pathway activation. cAMP and Ca
2þperturbations were performed
using Python scripting, using the E-cell system API. cAMP input was
realised by injecting a ﬁxed amount of cAMP molecules into the
system at one time. Ca
2þ inputs were simulated by repeatedly
increasing the calcium constant inﬂux over 2 s, separated by 2 s at
basal levels, triggering a series of short peaks. The basal constant
inﬂux is balanced by a constant decay of Ca
2þ ions, to simulate re-
uptake in the endoplasmic reticulum and buffering by calcium-
binding proteins. All the initial conditions are listed in Table 2.
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